Men exhibited lower than expected serum TT and SHBG levels in both groups [56], indicating that COVID-19, systemic inflammation, and certain medications, such as glucocorticoids, may hamper acutely testosterone secretion and transport, leading to male hypogonadism in all. This evidence concerns the gene SHBG and COVID-19.